In this therapy, ultrasound beams are focused on diseased tissue, and owing to the considerable energy deposition at the focus, temperature within the tissue can rise to levels from 65°C to 85°C, and destroy the diseased tissue by coagulation necrosis. The global HIFU therapy market was valued at $81,000 thousand in 2017, and is estimated to reach at $398,724 thousand by 2025, registering a CAGR of 21.8% from 2018 to 2025.
Upsurge in geriatric population, surge in prevalence of chronic disease such as cancer, and favorable regulatory scenario towards HIFU devices are the key factors that augment the growth of the global HIFU therapy market. Furthermore, rise in awareness for early disease diagnosis is expected to boost the market growth.
However, lack of skilled professionals and limitations associated with HIFU therapy are some of the factors that impede the market growth. Conversely, high potential of emerging economies and increase in demand of HIFU devices are expected to provide new opportunities for the market players in future.
The HIFU market is segmented based on application and region. On the basis of application, the market is categorized into prostate cancer, uterine fibroids, neurological disorders, aesthetics, and others. Region wise, it is analyzed across the North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of global HIFU therapy market.
Market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
A qualitative analysis based on innovative products and devices facilitate the strategic business planning.
The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
The list of key players operating in this market includes:
Chongqing Haifu Medical Technology Co., Ltd.
EDAP TMS S.A.
SonaCare Medical, LLC
ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.)
Image Guided Therapy S.A.
Merz Pharmaceuticals GmbH (Ulthera, Inc.)
Profound Medical Corp.
Shanghai A&S Technology Development Co., Ltd.
The OTHER PLAYERS included in the value chain analysis (and not included in the report) include:
Sonic Concepts, Inc.
Mianyang Sonic Electronic Ltd.
What is the estimated value of the Global HIFU Therapy Market?
What is the growth rate of the Global HIFU Therapy Market?
What is the forecasted size of the Global HIFU Therapy Market?
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
2.2. CXO perspective
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Top Player Positioning, 2017
3.4. Patent analysis, 2010-2018
3.4.1. Patent analysis, by year (2010-2018)
3.4.2. Patent analysis, by country
3.5. High-intensity focused ultrasound (HIFU): innovative products
3.5.2. Ulthera system
3.5.3. Exablate Neuro
3.6. Market dynamics
126.96.36.199. Favorable regulatory scenario
188.8.131.52. Rise in awareness for early disease diagnosis
184.108.40.206. Rapid increase in elderly population
220.127.116.11. Limitations of HIFU therapy
18.104.22.168. Dearth of skilled professionals
22.214.171.124. Untapped potential of the emerging economies
4.1.1. Market size and forecast
4.2. Prostate cancer
4.2.1. Market size and forecast
4.2.2. Market analysis, by country
4.3. Uterine fibroids
4.3.1. Market size and forecast
4.3.2. Market analysis, by country
4.4. Neurological disorders
4.4.1. Market size and forecast
4.4.2. Market analysis, by country
4.5.1. Market size and forecast
4.5.2. Market analysis, by country
4.6.1. Market size and forecast
4.6.2. Market analysis, by country
5.1.1. Market size and forecast
5.2. North America
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. North America HIFU market size and forecast, by country
126.96.36.199. U.S. market size and forecast
188.8.131.52. Canada market size and forecast
184.108.40.206. Mexico market size and forecast
5.2.3. North America HIFU market size and forecast, by Application
5.2.4. North America HIFU market size and forecast, by Industry
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Europe HIFU market size and forecast, by country
220.127.116.11. Germany market size and forecast
18.104.22.168. France market size and forecast
22.214.171.124. UK market size and forecast
126.96.36.199. Italy market size and forecast
188.8.131.52. Spain market size and forecast
184.108.40.206. Rest of Europe market size and forecast
5.3.3. Europe HIFU market size and forecast, by Application
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Asia-Pacific HIFU market size and forecast, by country
220.127.116.11. Japan market size and forecast
18.104.22.168. China market size and forecast
22.214.171.124. India market size and forecast
126.96.36.199. Australia market size and forecast
188.8.131.52. South Korea market size and forecast
184.108.40.206. Rest of Asia-Pacific market size and forecast
5.4.3. Asia-Pacific HIFU market size and forecast, by Application
5.5.1. Key market trends, growth factors and opportunities
5.5.2. LAMEA HIFU market size and forecast, by country
220.127.116.11. Brazil market size and forecast
18.104.22.168. Saudi Arabia market size and forecast
22.214.171.124. South Africa market size and forecast
126.96.36.199. Rest of LAMEA market size and forecast
5.5.3. LAMEA HIFU market size and forecast, by Application
6.1.1. Company overview
6.1.2. Company snapshot
6.1.3. Product portfolio
6.1.4. Key strategic moves and developments
6.2. EDAP TMS S.A.
6.2.1. Company overview
6.2.2. Company snapshot
6.2.3. Operating business segments
6.2.4. Product portfolio
6.2.5. Business performance
6.2.6. Key strategic moves and developments
6.3. ILJIN Holdings Co., Ltd. (ALPINION MEDICAL SYSTEMS Co., Ltd.)
6.3.1. Company overview
6.3.2. Company snapshot
6.3.3. Product portfolio
6.4. Merz Pharmaceuticals GmbH (Ulthera, Inc.)
6.4.1. Company overview
6.4.2. Company snapshot
6.4.3. Product portfolio
6.5. Theraclion SA
6.5.1. Company overview
6.5.2. Company snapshot
6.5.3. Business performance
6.5.4. Product portfolio
6.5.5. Key strategic moves and developments
6.6. Image Guided Therapy S.A.
6.6.1. Company overview
6.6.2. Company snapshot
6.6.3. Product portfolio
6.7. INSIGHTEC Ltd.
6.7.1. Company overview
6.7.2. Company snapshot
6.7.3. Product portfolio
6.8. Profound Medical Corp.
6.8.1. Company overview
6.8.2. Company snapshot
6.8.3. Product portfolio
6.8.4. Key strategic moves and developments
6.9. SonaCare Medical, LLC.
6.9.1. Company overview
6.9.2. Company snapshot
6.9.3. Product portfolio
6.10. Shanghai A&S Technology Development Co., Ltd.
6.10.1. Company overview
6.10.2. Company snapshot
6.10.3. Product portfolio
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.